PromarkerD distribution network expands to Britain

World’s first predictive diagnostic test for diabetic kidney disease to be sold in Great Britain under distribution deal with global diagnostic distributor, Apacor Limited.

Proteomics International Managing Director Dr Richard Lipscombe said: “After extensive due diligence, we identified Apacor as a great  partner for PromarkerD in Britain – they are well connected and we are already in contact with key bodies and opinion leaders to  promote the test and bring PromarkerD into the clinic.

The easy-to-use PromarkerD immunoassay platform allows hundreds of blood samples to be analysed quickly as part of a panel of routine blood tests and we expect this UK distribution deal to further drive global demand for the test,”.

ASX Release